Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapeutic benefit of suboptimally administered chemical compounds

Therapeutic benefit of suboptimally administered chemical compounds

US Patent 11491154 · Granted Nov 8, 2022

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutic benefit of suboptimally administered chemical compounds2025
Compositions and methods to improve the therapeutic benefit of suboptimally admi2025
Methods for sub-austenite transformation temperature deposition of inorganic par2024
Dianhydrogalactitol for the treatment of diffuse intrinsic pontine gliomas2023
Compositions and methods for detecting and/or treating inflammation2023
Use of dianhydrogalactitol and analogs or derivatives thereof in combination wit2023
Use of dianhydrogalactitol or derivatives or analogs thereof for treatment of pe2022
Use of substituted hexitols including dianhydrogalactitol and analogs to treat n2022
Use of dianhydrogalactitol and analogs and derivatives thereof to treat recurren2021
Compositions and methods for detecting and/or treating inflammation2021
Balancing RF circuit and control for a cross-coupled SIMO distribution network2020
Compositions and methods to improve the therapeutic benefit of indirubin and ana2019